Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dennis Kim, MD
Nammi Therapeutics Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sanai Medical Center
Los Angeles, California, United States
Recruiting - Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer
Los Angeles, California, United States
Recruiting - University of Southern California
Los Angeles, California, United States
Recruiting - Hoag Memorial Hospital Presbyterian
Newport, California, United States
Recruiting - Sarah Cannon Research Institute - Denver Ddu
Denver, Colorado, United States
Recruiting - Emory University - Winship Cancer Institute
Atlanta, Georgia, United States
Recruiting - New York Cancer & Blood Specialists
New York, New York, United States
Recruiting - University of Rochester - Wilmot Cancer Institute
Rochester, New York, United States
Recruiting - Start San Antonio
San Antonio, Texas, United States
Recruiting - Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Aug 2024
- Primary completion
- 31 Dec 2027
- Completion
- 30 May 2028
- Last update posted
- 13 Apr 2026
- Registered enrollment
- 100
- Registry id
- NCT06582017
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.